Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP01 - Early Stage/Localized Disease/Ablative Therapies

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Early Stage/Localized Disease/Ablative Therapies
    • +

      FP01.01 - The Association of Bevacizumab with a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505 in Completely Resected Stage IB-IIIA NSCLC

      00:00 - 00:00  |  Presenter: John Varlotto

      • Abstract

      Loading...

  • +

    P62 - Screening and Early Detection - Technological Advances for Detection and Prognostication of Early-Stage Lung Cancer

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Screening and Early Detection
    • +

      P62.02 - A Predictive Model to Guide Brain MRI Surveillance in Patients With Metastatic Lung Cancer: Impact on Real World Outcomes  

      00:00 - 00:00  |  Presenter: Julie Tsu-Yu Wu

      • Abstract

      Loading...

    • +

      P62.03 - Survival After Distant Recurrent Versus De Novo Stage IV Metastatic Lung Cancer Under Low-Dose Computed Tomography Screening

      00:00 - 00:00  |  Presenter: Chloe Chang Su

      • Abstract

      Loading...

  • +

    PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

    • 06:30 - 08:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab

      07:04 - 07:14  |  Presenter: Nasser Altorki

      • Abstract

      Loading...

    • +

      PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

      07:38 - 07:48  |  Presenter: Matthew Smeltzer

      • Abstract

      Loading...

  • +

    PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)

    • 14:30 - 16:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02A.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab

      15:04 - 15:14  |  Presenter: Nasser Altorki

      • Abstract

      Loading...

    • +

      PL02A.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

      15:38 - 15:48  |  Presenter: Matthew Smeltzer

      • Abstract

      Loading...

  • +

    WS03 - Women in Thoracic Oncology Workshop

    • 13:45 - 15:15
    • 9/11/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Workshop
    • Track: N.A.
  • +

    WS06 - Joint IASLC - CAALC - CSCO Workshop: Looking Toward the Future: Recognizing and Curing Lung Cancer

    • 22:15 - 23:45
    • 9/11/2021
    • Location: Program Auditorium
    • Not for CME Credit
    • Type: Workshop
    • Track: N.A.
    • +

      WS06.04 - Neoadjuvant/Adjuvant Immunotherapy for Curing Non-driver Genes Resectable NSCLC

      22:41 - 22:53  |  Presenter: Heather Wakelee

      • Abstract

      No abstract available for this presentation

  • +

    GA01 - IASLC General Assembly

    • 15:00 - 16:00
    • 9/12/2021
    • Location: Program Auditorium
    • Type: Highlights
    • Track: N.A.
    • +

      GA01.02 - Recognition of Outgoing & Incoming IASLC Board of Directors

      15:00 - 15:00  |  Presenter: Tetsuya Mitsudomi, Heather Wakelee

      • Abstract

      No abstract available for this presentation

    • +

      GA01.07 - Wrap Up & Adjourn

      15:00 - 15:00  |  Presenter: Heather Wakelee

      • Abstract

      No abstract available for this presentation

  • +

    PL04 - Plenary 4: Stigma as Risk Factor: Why You Should Care (Japanese, Mandarin, Spanish Translation Available)

    • 16:15 - 17:15
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL04.01 - Words Matter

      16:15 - 16:22  |  Presenter: Jill Feldman

      • Abstract

      No abstract available for this presentation

    • +

      PL04.02 - NLCRT Campaign to End Lung Cancer Stigma

      16:22 - 16:32  |  Presenter: Jamie L Studts

      • Abstract

      No abstract available for this presentation

    • +

      PL04.03 - Talk About Solutions: Empathic Communication Module, Language Guide, Projects and Deliverables in Stigma with Attention to the Intersection of Patients, Clinicians and Researchers

      16:32 - 16:42  |  Presenter: Jamie Ostroff, Smita Banerjee

      • Abstract

      No abstract available for this presentation

    • +

      PL04.04 - Psychological Distress and Stigma for People with Lung Cancer: Time to Act

      16:42 - 16:47  |  Presenter: Suzanne Chambers

      • Abstract

      Loading...

    • +

      PL04.05 - Stigma as Risk Factor - Why You Should Care

      16:47 - 16:52  |  Presenter: Kazuo Hasegawa

      • Abstract

      No abstract available for this presentation

    • +

      PL04.06 - ‘I Didn’t Smoke’ Language and Stigma Surrounding Lung Cancer (Personal Experience)

      16:52 - 16:55  |  Presenter: Gina Hollenbeck

      • Abstract

      No abstract available for this presentation

    • +

      PL04.07 - Live Discussion with Speakers

      16:55 - 17:15

      • Abstract

      No abstract available for this presentation